SC 13G

Company

Raphael Pharmaceutical Inc.

Filed

March 19, 2008

Accession Number

0001179591-08-000020

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →